Health
Anti-infective therapy for infections caused by drug-resistant gram-negative pathogens now in Phase I study – Outbreak News Today – Outbreak News Today
By NewsDesk @infectiousdiseasenews Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase…
By NewsDesk @infectiousdiseasenews
Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase 1 study of QPX9003, a next generation intravenous (IV)-administered synthetic polymyxin for infections caused by drug-resistant…
Continue Reading
-
Noosa News9 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General12 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba
-
General24 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup
-
General13 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia